| Name | L-aspartic acid |
|---|---|
| Synonyms |
Aspaginic acid
asparagic acid ASPTIC(L-) Aspatic acid (D) Solution, 100ppm L-Asptic Acid, Animal-Free L-AspticAcid L-Asptic Acid-1,C2 L-Asp-OH (2R)-2-aminobutanedioic acid H-Asp-OH ASPTIC ACID (S)-(+)-Aminosuccinic acid (S)-Aminobutanedioic acid (S)-Aminosuccinic Acid H-Asp-OH L-Aspaginic Acid L(+)-Asptic acid L-ASPTIC ACID, PH EUR L-Asparticacid L-ASPTIC ACID FREE ACID CELL CULTURETE STED aspaginicacid (S)-(+)-Aminosuccinic aci (R)-(−)-Aminosuccinic acid L-ASPTIC ACID, BIOXTRA, >= (HPL aspartic acid D-form L-ASPTIC ACID SIGMAULTRA L-AspticAcidForBiochemistry-(S)-2-AminosuccinicAcid) Aspatic acid (D) L-Asptic acid, (Titration: anhydrous basis) ASPTIC ACID, L-(P) 1-amino-1,2-carboxyethane L-Asplic add L-ASPTIC ACID, ( EE/GLC) L-ASPTIC ACID MIN Aspatofort aspagicacid (S)-Aminosuccinic Acid L-Aspaginic Acid H-Asp-OH hydrogen D-aspartate Aspagic acid L-Asptic acid (non-medicinal) L-Asptic Acid monocalcium alpha-Aminosuccinic acid L-Asptic acid,(S)-(+)-Aminosuccinic acid, (S)-Aminobutanedioic acid Acide (2R)-2-aminosuccinique L-ASPTIC ACID FREE ACID EINECS 200-291-6 L-Asptic Acid,(S)-Aminosuccinic Acid L-Aminobutanedioicacid δ-aspartic acid (s)-butanedioicaci QVYZ1VQ &&D or R Form (-)-Aspartic acid (2R)-2-Aminosuccinic acid MFCD00002616 L-asptic acid AJI92 Butanedioic acid, amino-, (S) L-ASPTIC ACIDRESECH ADE L-Asptic acid, Low metals content (S)-(+)-ASPTIC ACID aspaginsaeure L-AspticAcidForBiochemistry D-Aspartic acid H-D-Asp-OH aspacemic acid L-Asptic Acid FCC d-Asp Aspatic acid Solution (D) L-Asptic Joyce L-Asptic acid,(S)-(+)-Aminosuccinic acid, (S)-Aminobutanedioic acid, Acidum aspticum L-Asptic acid, extra , Ph Eur, BP L-ASPTIC ACID, ADE, >=98 aspaginsaure ASPTIC ACID, L Dl-AspticAcidPure Erlotinib-d7 HCl L-Asptic acid (H-Asp-OH) D-(-)-Aspartic acid l-aminosuccinic acid, h-asp-oh L(+)-Asptic acid, R |
| Description | L-Aspartic acid is is an amino acid, shown to be a suitable prodrug for colon-specific drug deliverly. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| In Vivo | L-Aspartic acid is shown to be a suitable prodrug for colon-specific drug deliverly[1]. L-[3H]Asp remaining in the brain at 5 min is increased by 206 and 178% by preadministration of 100 mM L-Aspartic acid and 100 mM L-Glu, respectively, whereas 100 mM D-Asp does not affect L-[3H]Asp efflux transport. That value for L-[3H]Glu at 20 min is increased by 145 and 156% by coadministration with 100 mM L-Aspartic acid and 100 mM L-Glu, respectively, but not by D-Asp. It is interesting that the apparent efflux rate of L-Aspartic acid across the BBB is sevenfold faster than that of L-Glu[2]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 264.1±30.0 °C at 760 mmHg |
| Melting Point | >300 °C (dec.)(lit.) |
| Molecular Formula | C4H7NO4 |
| Molecular Weight | 133.103 |
| Flash Point | 113.5±24.6 °C |
| Exact Mass | 133.037506 |
| PSA | 100.62000 |
| LogP | -0.67 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.531 |
| Water Solubility | 5 g/L (25 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi: Irritant;Xn: Harmful; |
| Risk Phrases | R36 |
| Safety Phrases | S26-S24/25-S22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | CI9098500 |
| HS Code | 29224995 |
| Precursor 8 | |
|---|---|
| DownStream 10 | |
| HS Code | 2922499990 |
|---|---|
| Summary | HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |